Literature DB >> 34301211

Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.

Lei Gao1, Ling Zhang2.   

Abstract

BACKGROUND: More and more studies have proven that circular RNAs (circRNAs) play vital roles in cancer development via sponging miRNAs. However, the expression pattern of competing endogenous RNA (ceRNA) in lung adenocarcinoma (LUAD) remains largely unclear. The current study explored functional roles and the regulatory mechanisms of circRNA as ceRNAs in LUAD and their potential impact on LUAD patient prognosis.
METHODS: In this study, we systematically screened differential expression circRNAs (DEcircRNAs), miRNAs (DEmiRNAs) and mRNAs (DEGs) associated with LUAD. Then, DEcircRNAs, DEmiRNAs and DEGs were selected to construct a circRNA-miRNA-mRNA prognosis-related regulatory network based on interaction information from the ENCORI database. Subsequently, the gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed on the genes in the network to predict the potential underlying mechanisms and functions of circRNAs in LUAD. In addition, Kaplan-Meier survival analysis was performed to evaluate clinical outcomes of LUAD patients, and drug sensitivity analysis was used to screen potential biomarkers for drug treatment of patients with LUAD.
RESULTS: As a result, 10 circRNAs were aberrantly expressed in LUAD tissues. The ceRNA network was built, which included 3 DEcircRNAs, 6 DEmiRNAs and 157 DEGs. The DEGs in the ceRNA network of hsa_circ_0049271 enriched in biological processes of cell proliferation and the Jak-STAT signaling pathway. We also detected 7 mRNAs in the ceRNA network of hsa_circ_0049271 that were significantly associated with the overall survival of LUAD patients (P < 0.05). Importantly, four genes (PDGFB, CCND2, CTF1, IL7R) identified were strongly associated with STAT3 activation and drugs sensitivity in GDSC.
CONCLUSIONS: In summary, a ceRNA network of hsa_circ_0049271 was successfully constructed, which including one circRNA, two miRNAs, and seven mRNAs. Seven mRNAs (PDGFB, TNFRSF19, CCND2, CTF1, IL11RA, IL7R and MAOA) were remarkably associated with the prognosis of LUAD patients. Among seven mRNA species, four genes (PDGFB, CCND2, CTF1, and IL7R) could be considered as drug targets in LUAD. Our research will provide new insights into the prognosis-related ceRNA network in LUAD.
© 2021. The Author(s).

Entities:  

Keywords:  Circular RNA; Competing endogenous RNA; Drug sensitivity; Lung adenocarcinoma; Microarray expression; Overall survival; Prognostic biomarker

Year:  2021        PMID: 34301211     DOI: 10.1186/s12885-021-08462-8

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  35 in total

Review 1.  The Biogenesis, Functions, and Challenges of Circular RNAs.

Authors:  Xiang Li; Li Yang; Ling-Ling Chen
Journal:  Mol Cell       Date:  2018-07-26       Impact factor: 17.970

2.  Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed.

Authors:  Agnieszka Rybak-Wolf; Christin Stottmeister; Petar Glažar; Marvin Jens; Natalia Pino; Sebastian Giusti; Mor Hanan; Mikaela Behm; Osnat Bartok; Reut Ashwal-Fluss; Margareta Herzog; Luisa Schreyer; Panagiotis Papavasileiou; Andranik Ivanov; Marie Öhman; Damian Refojo; Sebastian Kadener; Nikolaus Rajewsky
Journal:  Mol Cell       Date:  2015-04-23       Impact factor: 17.970

Review 3.  Lung cancer: current therapies and new targeted treatments.

Authors:  Fred R Hirsch; Giorgio V Scagliotti; James L Mulshine; Regina Kwon; Walter J Curran; Yi-Long Wu; Luis Paz-Ares
Journal:  Lancet       Date:  2016-08-27       Impact factor: 79.321

4.  Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.

Authors:  Zhenyu Zhong; Mengge Huang; Mengxin Lv; Yunfeng He; Changzhu Duan; Luyu Zhang; Junxia Chen
Journal:  Cancer Lett       Date:  2017-07-04       Impact factor: 8.679

5.  An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy.

Authors:  Lishuang Qi; Yang Li; Yuan Qin; Gengen Shi; Tianhao Li; Jiasheng Wang; Libin Chen; Yunyan Gu; Wenyuan Zhao; Zheng Guo
Journal:  Br J Cancer       Date:  2016-11-17       Impact factor: 7.640

Review 6.  The novel roles of circRNAs in human cancer.

Authors:  Qingfeng Shang; Zhi Yang; Renbing Jia; Shengfang Ge
Journal:  Mol Cancer       Date:  2019-01-09       Impact factor: 27.401

Review 7.  Circular RNAs in cancer: opportunities and challenges in the field.

Authors:  L S Kristensen; T B Hansen; M T Venø; J Kjems
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

8.  CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7.

Authors:  Kaixuan Zeng; Xiaoxiang Chen; Mu Xu; Xiangxiang Liu; Xiuxiu Hu; Tao Xu; Huiling Sun; Yuqin Pan; Bangshun He; Shukui Wang
Journal:  Cell Death Dis       Date:  2018-04-01       Impact factor: 8.469

Review 9.  Molecular roles and function of circular RNAs in eukaryotic cells.

Authors:  Lesca M Holdt; Alexander Kohlmaier; Daniel Teupser
Journal:  Cell Mol Life Sci       Date:  2017-11-07       Impact factor: 9.261

10.  A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer.

Authors:  Dong Hang; Jing Zhou; Na Qin; Wen Zhou; Hongxia Ma; Guangfu Jin; Zhibin Hu; Juncheng Dai; Hongbing Shen
Journal:  Cancer Med       Date:  2018-05-02       Impact factor: 4.452

View more
  7 in total

1.  Integrated Analysis of miRNA-mRNA Expression in Mink Lung Epithelial Cells Infected With Canine Distemper Virus.

Authors:  Qiang Chen; Mingwei Tong; Na Sun; Yong Yang; Yuening Cheng; Li Yi; Gaili Wang; Zhigang Cao; Quan Zhao; Shipeng Cheng
Journal:  Front Vet Sci       Date:  2022-05-31

2.  METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker.

Authors:  Yubin Zhou; Songhe Guo; Yiqiu Li; Fangfang Chen; Yaxian Wu; Yi Xiao; Jun An
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

3.  Endometriosis Associated-miRNome Analysis of Blood Samples: A Prospective Study.

Authors:  Sofiane Bendifallah; Yohann Dabi; Stéphane Suisse; Léa Delbos; Mathieu Poilblanc; Philippe Descamps; Francois Golfier; Ludmila Jornea; Delphine Bouteiller; Cyril Touboul; Anne Puchar; Emile Daraï
Journal:  Diagnostics (Basel)       Date:  2022-05-05

4.  Salivary MicroRNA Signature for Diagnosis of Endometriosis.

Authors:  Sofiane Bendifallah; Stéphane Suisse; Anne Puchar; Léa Delbos; Mathieu Poilblanc; Philippe Descamps; Francois Golfier; Ludmila Jornea; Delphine Bouteiller; Cyril Touboul; Yohann Dabi; Emile Daraï
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241

5.  A Bioinformatics Approach to MicroRNA-Sequencing Analysis Based on Human Saliva Samples of Patients with Endometriosis.

Authors:  Sofiane Bendifallah; Yohann Dabi; Stéphane Suisse; Ludmila Jornea; Delphine Bouteiller; Cyril Touboul; Anne Puchar; Emile Daraï
Journal:  Int J Mol Sci       Date:  2022-07-21       Impact factor: 6.208

6.  The prognostic value of immune-related genes AZGP1, SLCO5A1, and CTF1 in Uveal melanoma.

Authors:  Wanpeng Wang; Sha Wang
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

7.  Clues for Improving the Pathophysiology Knowledge for Endometriosis Using Serum Micro-RNA Expression.

Authors:  Yohann Dabi; Stéphane Suisse; Ludmila Jornea; Delphine Bouteiller; Cyril Touboul; Anne Puchar; Emile Daraï; Sofiane Bendifallah
Journal:  Diagnostics (Basel)       Date:  2022-01-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.